Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE28645 |
| Title | Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2 |
| Description | Analysis of endocrine-resistant LY2 breast cancer cells depleted of p160 steroid coactivator protein SRC-1 and treated with tamoxifen. SRC-1 is central to the development of the endocrine resistant phenotype. Results provide insight into the molecular basis of endocrine resistant breast cancer. |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28645 |
| Repository | Gene Expression Omnibus |
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
